What Covid vaccines cost - and the countries paying over the odds
Figures suggest that quicker vaccine rollouts are pay to play
The UK’s vaccination campaign is continuing at pace, with more than 33.5 million doses administered to patients across the country.
But while the figures on how many vaccines administered are clear-cut, the prices paid by countries worldwide for Covid jabs are not.
With governments worldwide vying to secure doses of the various vaccines being rolled out, some nations are paying well over the odds as different deals are struck.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Oxford-AstraZeneca
Figures released by the National Audit Office in December estimated that the UK had spent nearly £12bn on its vaccination campaign so far. The bill included £2.9bn paid for a total of 267 million doses of five different coronavirus vaccines.
The domestically produced Oxford-AstraZeneca vaccine costs the government around $3 (£2.17) per jab, according to the BMJ in January. The EU is paying $2.15 (£1.56) per dose of the UK-developed vaccine, the journal added, while the US is paying marginally more than the UK at $4 (£2.90) per jab.
Oxford University and AstraZeneca also released a joint statement in November pledging to make their vaccine available at cost price “in perpetuity” to low- and middle-incoming nations. But South Africa’s Health Ministry revealed in January that the price being paid there for the Oxford jab was $5.25 (£3.84), AFP reported - far more than the amount paid by most European nations.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Pfizer-BioNTech
According to the BBC, the Pfizer/BioNTech jab is costing the UK around £15 per dose.
Over in Israel, which is leading the global race to vaccinate populations, the authorities initially claimed to be paying the equivalent of £22 per dose of the Pfizer jab - substantially more than the UK is shelling out. And the price paid by the Israelis may be even higher, with a health official later telling public broadcaster Kan that each dose had actually cost his country £34.
Belgium’s budget state secretary Eva De Bleeker gave an insight into what the EU is paying when she accidentally tweeted a table in December that showed the price of each jab. The bloc is paying €12 (£10.60) for the Pfizer version.
The social media error was particularly embarrassing for the bloc as “the EU had undertaken to keep the prices confidential in return for discounts”, the BMJ says. The Twitter gaffe was also noted across the Atlantic, where The New York Times said the table showed that the US was paying above the odds for the Pfizer vaccine, at $19.50 (£14.27) per dose.
Moderna
The UK is believed to have spent between £24 and £28 per dose on the Moderna jab, the Daily Mail reports.
The vaccine’s development was partly subsidised by the US government and will cost the US about $15 (£10.86) a dose, while the EU is paying $18 (£13.03), the BMJ adds.
Israel is paying “$23.50 per dose on average” as part of a deal that saw the country “obtain early shipments”, the journal adds.
Sputnik V
In Russia, the manufacturers of the one-dose Sputnik vaccine said in a statement back in November that the cost of its vaccine “for international markets will be less than $10 per dose starting from February 2021”.
“Thus, Sputnik V will be two or more times cheaper than foreign vaccines based on mRNA technology with similar efficacy rates,” the company added. No reliable figures exist on what individual countries have paid for the Russian vaccine, with Hungary and Slovakia becoming the first EU countries to negotiate the purchase of the jab that is yet to be given approval by the European Medicines Agency.
-
Haitian gangs massacre hundreds accused of 'witchcraft'
Under the Radar Vodou practices blamed for gang leader's son's illness, as elderly are hacked to death in Port au Prince
By Harriet Marsden, The Week UK Published
-
Today's political cartoons - December 15, 2024
Cartoons Sunday's cartoons - a green agenda, vaccine skepticism, and more
By The Week US Published
-
5 humorously efficient cartoons about Trump's DOGE
Artists take on Trump's minions, wasteful spending, and more
By The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published